Role of Vasavaleha in the management of Covid19

Aamir Khan (1) , Rajni K. Gurmule (2)
(1) Department of Rachana Sharir, Mahatma Gandhi Ayurveda College Hospital and Research Centre, Salod (H), Wardha-442001, Datta Meghe institute of medical sciences (DU), Nagpur, Maharashtra, India, India ,
(2) Department of Rachana Sharir, Mahatma Gandhi Ayurveda College Hospital and Research Centre, Salod (H), Wardha-442001, Datta Meghe institute of medical sciences (DU), Nagpur, Maharashtra, India, India

Abstract

Vasavaleha is one of the best medicine given for respiratory diseases. Corona viruses typically affect the respiratory system, causing symptoms such as coughing, fever and shortness of breath. It also affects host immune system of human body. Spreading rate of this disease is very high. Whole world is seeking for the treatment which can uproots this diseases. There in no vaccine available till date against this pandemic disease. Ayurveda mainly focuses on prevention of diseases alongwith its total cure. Rajyakshma Vyadhi is MadhyamMarga Roga as per Ayurveda. It shows many symptoms such as Kasa, Shwasa etc.  By overall view of Covid 19, shows its resemblance with Rajyakshma Vyadhi  described in Ayurveda. Vasavaleha is a Kalpa  which is described in Rogadhikara of Rajyakshma. It shows Kasahara, Shwashara  properties. It consists of Vasa, Pipalli, Madhu and Goghrita. These components shows actions like bronchodilation, antitussive effect and many more other actions. Pipalli shows important Rasayana  effect. So in present review, we have tried to focus on role of Vasavaleha in the management of Covid 19. This can be used as preventive as well as adjuvant medication in treating Covid 19. There is need of further clinical research to rule of exact action of Vasavaleha  against Covid 19.

Full text article

Generated from XML file

Authors

Aamir Khan
Rajni K. Gurmule
rajni.gurmule@gmail.com (Primary Contact)
Aamir Khan, & Rajni K. Gurmule. (2020). Role of Vasavaleha in the management of Covid19. International Journal of Research in Pharmaceutical Sciences, 11((SPL 1), 259–261. Retrieved from https://ijrps.com/home/article/view/1443

Article Details

No Related Submission Found